Skip to search formSkip to main contentSkip to account menu

bleomycin/cyclophosphamide/doxorubicin/prednisone/vincristine protocol

Known as: CA-BOP, CHOP-B, BLEO/CTX/DOX/PRED/VCR 
A chemotherapy combination consisting of bleomycin, cyclophosphamide, doxorubicin, prednisone, and vincristine.
National Institutes of Health

Related topics

Related topics

8 relations

Broader (4)

Antineoplastic Combined Chemotherapy ProtocolsBleomycinCyclophosphamidecisplatin/cyclophosphamide/etoposide protocol
DoxorubicinDoxorubicin HydrochloridePrednisoneVincristine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Cytotoxic Components of Pereskia bleo (Kunth) DC. (Cactaceae) Leaves
Dihydroactinidiolide (1) and a mixture of sterols [campesterol (2), stigmasterol (3) and β-sitosterol (4)], together with the… 
Highly Cited
2006
Highly Cited
2006
Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center.
PURPOSE Advanced-stage follicular lymphoma is considered incurable. The pace of improvements in treatment has been slow. This… 
Highly Cited
1993
Highly Cited
1993
Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas.
PURPOSE Treatment of lymphomas with combination chemotherapy with or without radiation therapy (XRT) can result in long-term or… 
Highly Cited
1991
Highly Cited
1991
Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model.
We analyzed the records of 96 previously untreated patients with stage IV follicular low-grade lymphoma (FLGL) uniformly treated… 
Highly Cited
1990
Highly Cited
1990
Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma.
Thirty-four patients with stages IE and IIE gastric lymphoma were treated with chemotherapy and radiotherapy combinations without… 
Highly Cited
1986
Highly Cited
1986
Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma.
Previously untreated adult patients who presented with advanced diffuse large-cell lymphoma (DLCL) at diagnosis were studied to… 
Highly Cited
1977
Highly Cited
1977
Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP).
Seventy-three patients with advanced non-Hodgkin lymphoma were treated with bleomycin, Adriamycin, cyclophosphamide, vincristine… 
Highly Cited
1977
Highly Cited
1977
Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy.
Highly Cited
1977
Highly Cited
1977
Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphoma.
Forty-seven adults with advanced malignant lymphoma (the majority in stage IV) were treated with a combination of… 
Highly Cited
1976
Highly Cited
1976
Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.
A new combination chemotherapy program for patients with diffuse histiocytic and mixed histiocytic-lymphocytic lymphoma was… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License